May 6, 2021
DBV Technologies Announces Filing of its First Form 10-Q for the First Quarter of 2021
Montrouge, France, May 5, 2021 DBV Technologies Announces Filing of its First Form 10-Q for the First Quarter of 2021…
Pharmaceuticals, Biotechnology and Life Sciences
Montrouge, France, May 5, 2021 DBV Technologies Announces Filing of its First Form 10-Q for the First Quarter of 2021…
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, May 05, 2021 (GLOBE NEWSWIRE) — VAXIL BIO…
CHARLESTON, S.C., May 05, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a…
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES NOR…
ROCKVILLE, Md., May 04, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and…
On track to refile Libervant™ (diazepam) Buccal Film New Drug Application (NDA) by end of second quarter 2021Initiated first-in-human Phase…
BOTHELL, Wash., May 04, 2021 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and…
First-of-its-kind software predicts likelihood of off-target safety issues that could impede clinical progressPRINCETON, N.J., May 04, 2021 (GLOBE NEWSWIRE) —…
Vertically-integrated cannabis leader finishes quarter with multiple post-merger successes and strong position for future expansionSALINAS, Calif., May 04, 2021 (GLOBE…
Transformative, leading allogeneic NKT cell platform technology expands Athenex’s cell therapy development capabilityPlatform has broad applications based on transducing NKT…